The FDA Is Requiring Ozempic, Wegovy and Other GLP-1 Drugs to Warn of a Rare Condition That Can Permanently Damage Vision
Sudden vision loss in 1 eye, often without pain, is the risk behind the FDA’s November 9 requirement for new warnings on Ozempic, Wegovy and every other approved GLP-1 drug. The condition, NAION, c…
10 Nov 12:45 · Thought Catalog